ATRA · Atara Biotherapeutics, Inc.
$7.90
-0.27 (-3.30%)
At close · Jul 24
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed May 12, 2026
Market Cap
$71.18M
Shares
9.01M
No listed options were found for ATRA.